Is IJS a Good Investment? The Case For and Against (2026)

IJS holds the value side of the S&P SmallCap 600, which makes it the product of two consecutive screens. Entry to the 600 requires a record of positive earnings, so persistently loss-making companies never reach the pool. The value split then keeps those trading cheaply against book value, earnings and sales. Molina Healthcare leads the real positions at 1.3%, followed by Match Group at 1.0%, with financials the largest sector at 20%. The fund charges 0.18%, yields 1.32% and holds $8.0B, dating back to 2000.

Largest holdings (approximate as of August 2026; verify on iShares's fund page):

Two filters stack here: the S&P 600 requires profits, and the value half then requires a low price on top of that.

In its favour: it gives you the S&P SmallCap 600 Value Index exposure in one ticker at a 0.18% expense ratio, which is simple to hold and cheap to own.

• Cost vs alternatives: 0.18% is the fee; compare it to funds tracking a similar index.
• Concentration: check how much of IJS sits in its largest holdings (MOH, MTCH, EMN).
• Overlap: if you already own a broad-market fund, you may already hold much of this.
• Tracking scope: IJS only gives you the S&P SmallCap 600 Value Index; it will not capture what sits outside that index.

“Diversified” is the word every index fund uses and it hides a wide range. The number that actually matters is how much of the fund sits in its largest positions, because that is the part that drives the return. In IJS, the three largest positions are about 3.1% of the fund and the 9 largest are about 7.6%, with the single biggest at roughly 1.3%. Those are approximate weights as of August 2026, and because this is the published top 9 rather than the full book, treat 7.6% as a floor on concentration rather than the whole picture. Verify with iShares.

That is a well spread fund. No small group of names drives it, so the return will track its index closely rather than the fortunes of a handful of companies.

This is also the number that decides whether IJS adds diversification to your portfolio rather than to a portfolio in the abstract. A fund can be well spread on its own and still concentrate you further, if its largest holdings are names you already own directly or through another fund. That is a question about your account rather than about IJS, and it is the one worth answering before you buy.

A fund is defined as much by what it leaves out as by what it holds, and the exclusions are rarely on the marketing page. IJS tracks the S&P SmallCap 600 Value Index, so anything outside that index is simply absent from your portfolio no matter how much of the fund you own.

In practice that means checking three gaps. Whether the geography you want is covered, since a US index holds no international companies and a developed-markets index holds no emerging ones. Whether the size band you want is covered, because a large-cap index excludes the smaller companies some investors specifically want exposure to. And whether the asset class you want is covered at all, since an equity fund holds no bonds and gives you nothing to rebalance against in a drawdown.

None of these are faults. They are the fund doing exactly what it says. The mistake is assuming that owning a diversified fund means being diversified, when it means being diversified within one index.

Being specific about this is more useful than another paragraph on why it might be right.

• You already own most of it. If a broad-market fund you hold already contains MOH, MTCH, EMN at meaningful weight, adding IJS mostly increases your exposure to the same companies while adding a second fee. That is the single most common way people accidentally concentrate.
• You want the exposure for a short horizon. An index fund is a way to own an asset class over years. Over months it is simply the index, with all of the index's volatility and none of the compounding that makes holding it worthwhile.
• You need income you can rely on. Distributions from an equity index fund vary with what the underlying companies pay, so they are not a schedule you can plan around the way a bond ladder is.
• A cheaper fund tracks the same thing. Where two funds follow a similar index, the difference in expense ratio is one of the few advantages available to you without taking extra risk. Compare before assuming 0.18% is competitive.

The useful question is rarely “will IJS go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how IJS would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.

The bottom line: IJS is a low-cost core building block for the S&P SmallCap 600 Value Index exposure, not a tactical bet on a single name. If you want the S&P SmallCap 600 Value Index exposure and the 0.18% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.

• What is IJS? (holdings, cost, performance, and the themes it covers)
• IJS dividend: yield and schedule